Skip to main content

Table 1 Participants characteristics at 48 weeks on ART

From: Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study

Variable Category Frequency (%)
Outcome of participants Completed 180 (70.3%)
Lost to follow up 76 (29.6%)
Gender Female 108 (60%)
Male 72 (40%)
Age (years) Median 39
≤ 25 years 8 (4%)
26 – 31 years 20 (11%)
32–37 years 52 (29%)
38–43 years 48 (27%)
44–49 years 28 (16%)
≥ 50 years 24 (13%)
ART regimen EFV 100 (55.5%)
NVP 80 (44.4%)
  1. Abbreviations: ART Antiretroviral therapy, EFV Efavirenz, NVP Nevirapine